Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Identification of HIV-1 latency biomarkers by systems-biology analysis of T-cell signaling and function

EF 2013-14

Résumé
Despite the success of anti-retroviral therapy, HIV/AIDS is an incurable disease. For the 34 million people living with HIV/AIDS worldwide, HIV persistence results in a lifetime of therapy, side effects, social stigma, and the threat of emerging drug resistance. HIV persistence results from the ability of the virus to form dormant infections in immune memory cells. Dormant HIV is insusceptible to anti-retroviral therapy and invisible to the immune system, thereby making it stable for the lifetime of the individual and very difficult to treat. By understanding the mechanisms by which HIV forms dormant infections, scientists hope to develop new types of therapies to coax HIV out of dormancy. Such an approach could, if successful, result in the first true cure for HIV/AIDS. Developing therapeutics to target dormant HIV requires a comprehensive understanding of the viral mechanisms leading to dormancy. Many potential individual mechanisms for dormancy have been independently identified, yet there is little overlap between studies. This is due, in large part, to an inability to study early determinants of HIV dormancy, and an inability to study multiple parameters simultaneously. In the proposed study, we will combine three recently developed technologies to interrogate HIV persistence in a never-before-seen-way. More specifically, we will use a novel model of dormant HIV that allows identification of dormant infected cells in their native state and without perturbing factors responsible for dormancy. We will couple this to a novel technology that allows for high-throughput, single-cell interrogation of immune cell function, activation state, and signalling. In this way, the unique combination of approaches in this proposal promise to offer an unprecedentedly detailed and comprehensive view of the mechanisms driving HIV dormancy. We believe that this knowledge will be crucial in the fight to eradicate HIV/AIDS.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
301001
Name
Dahabieh Matthew S
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identification of HIV-1 latency biomarkers by systems-biology analysis of T-cell signaling and function
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Hiv/Aids; Immunology; Latency; Systems Biology; T Cells; Transcription; Virology
Abstract
Despite the success of anti-retroviral therapy, HIV/AIDS is an incurable disease. For the 34 million people living with HIV/AIDS worldwide, HIV persistence results in a lifetime of therapy, side effects, social stigma, and the threat of emerging drug resistance. HIV persistence results from the ability of the virus to form dormant infections in immune memory cells. Dormant HIV is insusceptible to anti-retroviral therapy and invisible to the immune system, thereby making it stable for the lifetime of the individual and very difficult to treat. By understanding the mechanisms by which HIV forms dormant infections, scientists hope to develop new types of therapies to coax HIV out of dormancy. Such an approach could, if successful, result in the first true cure for HIV/AIDS. Developing therapeutics to target dormant HIV requires a comprehensive understanding of the viral mechanisms leading to dormancy. Many potential individual mechanisms for dormancy have been independently identified, yet there is little overlap between studies. This is due, in large part, to an inability to study early determinants of HIV dormancy, and an inability to study multiple parameters simultaneously. In the proposed study, we will combine three recently developed technologies to interrogate HIV persistence in a never-before-seen-way. More specifically, we will use a novel model of dormant HIV that allows identification of dormant infected cells in their native state and without perturbing factors responsible for dormancy. We will couple this to a novel technology that allows for high-throughput, single-cell interrogation of immune cell function, activation state, and signalling. In this way, the unique combination of approaches in this proposal promise to offer an unprecedentedly detailed and comprehensive view of the mechanisms driving HIV dormancy. We believe that this knowledge will be crucial in the fight to eradicate HIV/AIDS.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Dahabieh, Matthew S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~